Wuhan YZY Biopharma Co., Ltd. Class H (HK:2496) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Wuhan YZY Biopharma Co., Ltd. has announced the composition of its Board of Directors, which includes Executive Director Dr. Zhou Pengfei, who also serves as Chairman and CEO, alongside a mix of Non-executive and Independent Non-executive Directors. The Board has established three committees: Audit, Nomination, and Remuneration, each chaired by a designated member and consisting of various directors.
For further insights into HK:2496 stock, check out TipRanks’ Stock Analysis page.